Posted on

Survodutide (BI 456906): Dual GLP-1/Glucagon Receptor Agonist in Metabolic and MASH Research

3D scientific illustration of Survodutide dual GLP-1 and glucagon receptor agonist interaction

Survodutide is a dual GLP-1 and glucagon receptor agonist demonstrating potent efficacy across clinical trials for obesity, metabolic dysfunction, and stea

Read more Survodutide (BI 456906): Dual GLP-1/Glucagon Receptor Agonist in Metabolic and MASH Research